rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: macleods pharmaceuticals limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler macleods pharmaceuticals limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 6 mg/1

Manufacturer
Macleods Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 33342-092
Product ID 33342-092_3ac90f1e-d2a5-4645-972b-0d627e4cc860
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203148
Listing Expiration 2026-12-31
Marketing Start 2014-09-02

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 33342092
Hyphenated Format 33342-092

Supplemental Identifiers

RxCUI
312835 312836 314214 314215
UPC
0333342089090 0333342091093 0333342090096
UNII
9IY2357JPE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA203148 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/1
source: ndc
Packaging
  • 3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-06) / 10 CAPSULE in 1 BLISTER PACK
  • 60 CAPSULE in 1 BOTTLE (33342-092-09)
  • 10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-12) / 10 CAPSULE in 1 BLISTER PACK
  • 500 CAPSULE in 1 BOTTLE (33342-092-15)
source: ndc

Packages (4)

33342-092-06 3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-06) / 10 CAPSULE in 1 BLISTER PACK 33342-092-09 60 CAPSULE in 1 BOTTLE (33342-092-09) 33342-092-12 10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-12) / 10 CAPSULE in 1 BLISTER PACK 33342-092-15 500 CAPSULE in 1 BOTTLE (33342-092-15)

Ingredients (1)

rivastigmine tartrate (6 mg/1)

Linked Drug Pages (1)

RIVASTIGMINE TARTRATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3ac90f1e-d2a5-4645-972b-0d627e4cc860", "openfda": {"upc": ["0333342089090", "0333342091093", "0333342090096"], "unii": ["9IY2357JPE"], "rxcui": ["312835", "312836", "314214", "314215"], "spl_set_id": ["4364f6ef-a8da-4805-be0d-aabbe8ca2d21"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-06)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "33342-092-06", "marketing_start_date": "20140902"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (33342-092-09)", "package_ndc": "33342-092-09", "marketing_start_date": "20140902"}, {"sample": false, "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-092-12)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "33342-092-12", "marketing_start_date": "20140902"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (33342-092-15)", "package_ndc": "33342-092-15", "marketing_start_date": "20140902"}], "brand_name": "RIVASTIGMINE TARTRATE", "product_id": "33342-092_3ac90f1e-d2a5-4645-972b-0d627e4cc860", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "33342-092", "generic_name": "RIVASTIGMINE TARTRATE", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIVASTIGMINE TARTRATE", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "6 mg/1"}], "application_number": "ANDA203148", "marketing_category": "ANDA", "marketing_start_date": "20140902", "listing_expiration_date": "20261231"}